What are the guideline sources, guidelines and references for Allergic bronchopulmonary aspergillosis ?
Guideline sources The following summarized guidelines for the evaluation and management of allergic bronchopulmonary aspergillosis (ABPA) are prepared by our editorial team based on guidelines from the Infectious Diseases Society of America (IDSA 2016) and the American Thoracic Society (ATS 2011). 1 2 Calculator Calculator ISHAM criteria for allergic bronc Rosenberg-Patterson criteria for Guidelines 1. Diagnostic investigations Immunoglobulin E: obtain Aspergillus IgE and total IgE for screening and to establish the diagnosis. A 2. Medical management Antifungal therapy: https://web.pathway.md/diseases/recW9gfrXTTJuzchh 1/2 6/23/23, 2:18 AM Allergic bronchopulmonary aspergillosis Pathway Consider initiating oral itraconazole with therapeutic drug monitoring in symptomatic patients with asthma and bronchiectasis or mucoid impaction despite oral or ICS therapy. C Consider initiating oral itraconazole in patients with cystic fibrosis experiencing frequent exacerbations and/or falling FEV in 1 second to minimize corticosteroid use with therapeutic drug monitoring. Consider initiating other mold-active azole therapies if therapeutic levels cannot be achieved. C Corticosteroids: initiate prednisone (or other corticosteroid equivalent) at a starting dose of 0.5 mg/kg/day, with the dose tapering as indicated by symptom improvement, in patients with ABPA. A Show 3 more Bronchodilators: consider offering bronchodilators in selected patients with mild exacerbations of ABPA. C Leukotriene antagonists: consider offering leukotriene antagonists in selected patients with mild exacerbations of ABPA. C Serial monitoring: obtain regular monitoring of serum IgE levels, serial monitoring of pulmonary function tests, and chest imaging in all patients with ABPA. Adjust the corticosteroid dosing when imaging evidence, such as infiltrates, mucoid impaction, fibrosis, or worsening bronchiectasis, is present. B References 1. Andrew H Limper, Kenneth S Knox, George A Sarosi et al. An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011 Jan 1;183 1 96 128. Open 2. Patterson TF, Thompson GR rd, Denning DW et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Aug 15;63 4):e1-e60. Open 3. R Agarwal, A Chakrabarti, A Shah et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013 Aug;43 8 850 73. Open 4. M Rosenberg, R Patterson, R Mintzer et al. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1977 Apr;86 4 405 14. Open https://web.pathway.md/diseases/recW9gfrXTTJuzchh 2/2